← FDA Drug Approvals (Drugs@FDA)

AKLIEF

NDA · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2019-10-04

Drug application

FDA Application #

NDA211527

Application type

New Drug Application

Brand name

AKLIEF

Generic name

TRIFAROTENE

Active ingredients

TRIFAROTENE

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

GALDERMA LABS LP

Manufacturer

Galderma Laboratories, L.P.

First approval

2019-10-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown